𝔖 Bobbio Scriptorium
✦   LIBER   ✦

No germline TP53 mutations detected in familial and bilateral testicular cancer

✍ Scribed by Ketil Heimdal; Ragnhild A. Lothe; Sigrid Lystad; Ruth Holm; Sophie D. Fosså; Prof. Anne-Lise Børresen


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
448 KB
Volume
6
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Mutations in the TP53 gene are considered to be among the most common genetic alterations in human cancers. Both somatic and germline mutations have been found. Using polymerase chain reaction (PCR). constant denaturant gel electrophoresis (CDGE), and denaturing gradient gel electrophoresis (DGGE), we have examined 32 patients with bilateral and familial germ cell tumors (GCT) and two patients with sporadic GCT for germline mutations within the conserved regions of the gene. In addition, I5 tumors were screened for somatic mutations and analyzed for loss of heterozygocity (LOH) at the TP53 locus.

Twelve tumors were analyzed for expression of TP53 via immunohistochemistry. Neither germline nor somatic TP53 mutations were detected. LOH was observed in one of five informative cases. No tumors showed increased expression of TP53 protein.

These results indicate that alterations in the JP53 gene are not important for the predisposition to and development of GCT.


📜 SIMILAR VOLUMES


TP53 mutations in familial breast cancer
✍ Milena Gasco; Isik G Yulug; Tim Crook 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Mutation in p53 (TP53) remains one of the most commonly described genetic events in human neoplasia. The occurrence of mutations is somewhat less common in sporadic breast carcinomas than in other cancers, with an overall frequency of about 20%. There is, however, evidence that p53 is mutated at a s

BRCA1 germline mutations in Indian famil
✍ Mani T. Valarmathi; Agarwal A.; Suryanarayana S. V. Deo; Nootan K. Shukla; Satya 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

Germline mutation analysis of BRCA1 gene has demonstrated significant allelic heterogeneity. These differences represent historical influences of migration, population structure and geographic or cultural isolation. To date, there have been no reports of Indian families with mutations in BRCA1. We h

No TP53 mutations in neuroblastomas dete
✍ Javier S. Castresana; M. Josefa Bello; Juan A. Rey; Paloma Nebreda; Antonio Quei 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB

We have analyxed 29 neuroblastomas for TP53 mutations in exons 5 to 8 by means of the polymerase chain reaction in combination with the single-strand conformation polymorphism technique. We could not detect any mutation. These results indicate that, in contrast to the majority of tumors so far studi

BRCA2 germline mutations in Cypriot pati
✍ Andreas Hadjisavvas; Elpida Charalambous; Adamos Adamou; Christina G. Christodou 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB 👁 2 views

Germline mutations in the BRCA2 gene have been shown to be associated with familial female and male breast cancer. Mutations occur throughout the entire coding region of the gene, and there is considerable ethnic and geographical diversity in the deleterious mutations detected in different populatio

Screening of germline mutations in the C
✍ Anton Platz; Johan Hansson; Ulrik Ringborg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 61 KB 👁 2 views

Germline mutations within the CDKN2A gene, coding for the cyclin-dependent kinase inhibitor p16, have been detected by screening in 8% of Swedish families with an inheritance of cutaneous melanoma (FMM) and dysplastic nevus syndrome (DNS). Contrastingly, the closely related gene CDKN2B had no diseas

Somatic mutations and germline sequence
✍ Alexandra E. Gylfe; Johanna Sirkiä; Manuel Ahlsten; Heikki Järvinen; Jukka-Pekka 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 204 KB 👁 1 views

## Abstract It is estimated that up to 35% of colorectal cancers (CRC) can be explained by hereditary factors. However, genes predisposing to highly penetrant CRC syndromes account for only a small fraction of all cases. Thus, most CRCs still remain molecularly unexplained. A recent systematic sequ